4.4 Article

Hereditary Parathyroid Disease: Sometimes Pathologists Do Not Know What They Are Missing

期刊

ENDOCRINE PATHOLOGY
卷 31, 期 3, 页码 218-230

出版社

HUMANA PRESS INC
DOI: 10.1007/s12022-020-09631-4

关键词

Parathyroid; CDC73; Adenoma; Jaw tumours; MEN; FHH

向作者/读者索取更多资源

Parathyroid gland excision specimens are common and sometimes underestimated cases that many surgical pathologists encounter regularly. In the vast majority of cases, these will be spot diagnoses of sporadic primary parathyroid adenomas or, perhaps, hyperplasias commonly in the setting of renal failure. However, a small but significant number of parathyroid gland excisions may be due to heritable disease. In most cases, hereditary disease is suspected by the referring clinicians. Nevertheless, a subset of these are undetected which is significant, particularly in the setting of the multiple endocrine neoplasia (MEN), and the hyperparathyroidism jaw tumour (HPT-JT) syndromes. There have been recent advances in recognition of the morphological and immunohistochemical characteristics of these tumours and hyperplasias. While hereditary kindreds are over-represented at specialist referral centres, with awareness of the characteristic clinical and morphological features, the general surgical pathologist is frequently able to suggest the possibility of hereditary parathyroid disease. We therefore provide a succinct guide for pathologists to increase the recognition of hereditary parathyroid disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Surgery

The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer

Stephan B. Dreyer, Sarah Rae, Kirsty Bisset, Rosie Upstill-Goddard, Georgios Gemenetzis, Amber L. Johns, Euan J. Dickson, Anubhav Mittal, Anthony Gill, Fraser T. Duthie, Antonio Pea, Rita Lawlor, Aldo Scarpa, Roberto Salvia, Alessandra Pulvirenti, Alessandro J. Zerbi, Federica V. Marchesi, Colin S. McKay, Andrew K. Biankin, Jaswinder B. Samra, David K. Chang, Nigel Jamieson

Summary: The aim of this study was to evaluate the performance of molecular subtypes in traditional staging criteria for pancreatic ductal adenocarcinoma (PDAC). The results showed that TNM staging criteria and margin status only have prognostic value in tumors with classical pancreatic subtype. Patients with squamous subtype tumors have a poor outcome regardless of favorable traditional pathological staging, and margin status has no impact on survival in squamous subtype.

ANNALS OF SURGERY (2023)

Article Surgery

Development and External Validation of a Model to Predict Overall Survival in Patients With Resected Gallbladder Cancer

Elise A. J. de Savornin Lohman, T. J. J. de Bitter, G. Hannink, M. F. T. Wietsma, E. Vink-Borger, I. D. Nagtegaal, T. J. Hugh, A. J. Gill, N. Bhimani, M. Seyed Ahadi, R. S. van der Post, Philip R. de Reuver

Summary: The study aimed to develop and validate a clinical prediction model for overall survival in patients with nonmetastatic, resected gallbladder cancer (GBC). Data from a Dutch cohort was used for development and an Australian cohort for external validation. The proposed model demonstrated superior discriminatory capacity compared to the AJCC staging system and can be a useful tool for physicians and patients.

ANNALS OF SURGERY (2023)

Article Pathology

Immunohistochemistry for FOSB and FOS is a Useful Ancillary Tool in the Diagnosis of Epithelioid Hemangioma but There are Pitfalls in Interpretation Including Expression in Other Vascular Lesions

Kwan Yee Tsui, Fiona Maclean, Denis Moir, Alison Cheah, Fiona Bonar, Joel Tabot, Anthony J. Gill, A. Cristina Vargas

Summary: This study aimed to determine the expression of FOS and FOSB in epithelioid hemangiomas and compare it with other vascular lesions. The results showed a high expression rate of FOSB, and the use of both antibodies increased the detection rate of epithelioid hemangiomas.

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2023)

Letter Pathology

Primary pancreatic spindle cell sarcoma with a TMEM106B::BRAF gene fusion treated with MEK inhibition

C. Mitchell, V. Malalasekera, A. J. Gill, J. H. A. Vissers, S. J. Luen, S. M. Grimmond, J. Lewin

PATHOLOGY (2023)

Article Surgery

Transition from open to robotic distal pancreatectomy in a low volume pancreatic surgery country: a single Australian centre experience

Hiro Masuda, Krishna Kotecha, Tamara Gall, Anthony J. Gill, Anubhav Mittal, Jaswinder S. Samra

Summary: This study examines the experience of a surgeon in Australia during the transition to robotic distal pancreatectomy. The results show that robotic distal pancreatectomy is feasible and safe in a traditionally low-volume country like Australia.

ANZ JOURNAL OF SURGERY (2023)

Correction Multidisciplinary Sciences

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes (vol 578, pg 102, 2020)

Esther Rheinbay, Morten Muhlig Nielsen, Federico Abascal, Jeremiah A. Wala, Ofer Shapira, Grace Tiao, Henrik Hornshoj, Julian M. Hess, Randi Istrup Juul, Ziao Lin, Lars Feuerbach, Radhakrishnan Sabarinathan, Tobias Madsen, Jaegil Kim, Loris Mularoni, Shimin Shuai, Andres Lanzos, Carl Herrmann, Yosef E. Maruvka, Ciyue Shen, Samirkumar B. Amin, Pratiti Bandopadhayay, Johanna Bertl, Keith A. Boroevich, John Busanovich, Joana Carlevaro-Fita, Dimple Chakravarty, Calvin Wing Yiu Chan, David Craft, Priyanka Dhingra, Klev Diamanti, Nuno A. Fonseca, Abel Gonzalez-Perez, Qianyun Guo, Mark P. Hamilton, Nicholas J. Haradhvala, Chen Hong, Keren Isaev, Todd A. Johnson, Malene Juul, Andre Kahles, Abdullah Kahraman, Youngwook Kim, Jan Komorowski, Kiran Kumar, Sushant Kumar, Donghoon Lee, Kjong-Van Lehmann, Yilong Li, Eric Minwei Liu, Lucas Lochovsky, Keunchil Park, Oriol Pich, Nicola D. Roberts, Gordon Saksena, Steven E. Schumacher, Nikos Sidiropoulos, Lina Sieverling, Nasa Sinnott-Armstrong, Chip Stewart, David Tamborero, Jose M. C. Tubio, Husen M. Umer, Liis Uuskuela-Reimand, Claes Wadelius, Lina Wadi, Xiaotong Yao, Cheng-Zhong Zhang, Jing Zhang, James E. Haber, Asger Hobolth, Marcin Imielinski, Manolis Kellis, Michael S. Lawrence, Christian von Mering, Hidewaki Nakagawa, Benjamin J. Raphael, Mark A. Rubin, Chris Sander, Lincoln D. Stein, Joshua M. Stuart, Tatsuhiko Tsunoda, David A. Wheeler, Rory Johnson, Jueri Reimand, Mark Gerstein, Ekta Khurana, Peter J. Campbell, Nuria Lopez-Bigas, Joachim Weischenfeldt, Rameen Beroukhim, Inigo Martincorena, Jakob Skou Pedersen, Gad Getz

NATURE (2023)

Article Pathology

A novel prognostic nomogram for predicting survival in diffuse pleural mesothelioma

Yagiz Aksoy, Angela Chou, Mahiar Mahjoub, Amy Sheen, Loretta Sioson, Mahsa S. Ahadi, Anthony J. Gill, Talia L. Fuchs

Summary: Recent advances in the management of Diffuse Pleural Mesothelioma (DPM) have increased interest in prognostication and risk stratification. Predictive modelling using deep learning algorithms is regarded as the gold standard in prognostication. We developed and validated a prognostic nomogram for DPM, which incorporates well-established prognostic markers and demonstrates excellent predictive capability.

PATHOLOGY (2023)

Article Otorhinolaryngology

SDH deficiency is very common in carotid body paragangliomas: Genetic counseling and testing should be offered to all patients

Leba Michael Sarkis, Rory Clifton-Bligh, David Veivers, Anthony James Gill

Summary: This study aimed to estimate the prevalence of succinate dehydrogenase (SDH) deficiency in patients with carotid body paragangliomas. Out of 64 identified cases, 43 (67%) were found to be SDH-deficient. These findings suggest that genetic testing and counseling should be offered to all patients with carotid body paragangliomas.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2023)

Article Endocrinology & Metabolism

Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma

Nicholas Kesby, Robert Mechera, Talia Fuchs, Alexander Papachristos, Matti Gild, Venessa Tsang, Roderick Clifton-Bligh, Bruce Robinson, Mark Sywak, Stan Sidhu, Angela Chou, Anthony J. Gill, Anthony Glover

Summary: This study reports the outcomes of surgically managed sporadic micro-MTC and identifies factors associated with recurrence and disease-specific survival. Most sporadic micro-MTCs are incidentally detected and generally have good outcomes. Personalized management can be achieved by considering grade, lymph node metastasis, and postoperative calcitonin levels.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Medicine, General & Internal

The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer

Sarah Maloney, Nick Pavlakis, Malinda Itchins, Jennifer Arena, Anubhav Mittal, Amanda Hudson, Emily Colvin, Sumit Sahni, Connie Diakos, David Chan, Anthony J. Gill, Jaswinder Samra, Stephen J. Clarke

Summary: Pancreatic cancer has low survival rates, and there are currently no available biomarkers to predict chemotherapy response or prognosis. However, studies have shown that higher neutrophil-to-lymphocyte ratios are associated with worse prognosis. Our study found that patients with a neutrophil-to-lymphocyte ratio >5 at diagnosis had shorter median overall survival compared to those with ratios <= 5. Additionally, a higher platelet-to-lymphocyte ratio was weakly correlated with increased residual tumor in patients receiving neoadjuvant chemotherapy.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Cell Biology

Pathological features associated with metastasis in patients with early invasive (pT1) colorectal carcinoma in colorectal polyps

Ian Brown, Andrew P. Zammit, Mark Bettington, Caroline Cooper, Anthony J. Gill, Agoston Agoston, Robert Odze

Summary: Most malignant colorectal polyps with adverse histological features do not have lymph node metastases at the time of resection, so there is a need for better refinement of histological risk factors. This study found that larger tumor size, vascular invasion, and poor tumor differentiation were associated with a higher risk for metastasis. A predictive model including factors such as vascular invasion, tumor budding, tumor width and depth, and peritumoral desmoplasia showed excellent performance in predicting metastatic disease.

HISTOPATHOLOGY (2023)

Letter Endocrinology & Metabolism

Response to Letter to the Editor From Devgan and Mayilvaganan: Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma

Nicholas Kesby, Robert Mechera, Talia Fuchs, Alexander Papachristos, Matti Gild, Venessa Tsang, Roderick Clifton-Bligh, Bruce Robinson, Mark Sywak, Stan Sidhu, Angela Chou, Anthony J. Gill, Anthony Glover

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Review Oncology

Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single-cell analysis

Sooin Byeon, Taymin du Toit-Thompson, Josef Gillson, Anthony J. Gill, Jaswinder S. Samra, Anubhav Mittal, Sumit Sahni

Summary: Background: Pancreatic ductal adenocarcinoma is one of the deadliest malignancies in the world, and its mortality rate is predicted to be the second-highest cause of cancer-related deaths by 2030. Methods: This review focuses on the use of single-cell RNA sequencing and other single-cell analysis technologies to uncover the heterogeneity of pancreatic ductal adenocarcinoma in different cellular subpopulations. Results and Conclusion: The application of single-cell RNA sequencing has revealed associations between disease progression and heterogeneity in the pancreatic tumor microenvironment, which could have implications for future treatment strategies.

CANCER MEDICINE (2023)

Article Oncology

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy

Sumit Sahni, Christopher Nahm, Mahsa S. S. Ahadi, Loretta Sioson, Sooin Byeon, Angela Chou, Sarah Maloney, Elizabeth Moon, Nick Pavlakis, Anthony J. J. Gill, Jaswinder Samra, Anubhav Mittal

Summary: This study aimed to identify key differences in gene expression profile in tumors from chemoresponsive and chemoresistant patients. The results showed a distinct gene expression profile between good- and poor-chemotherapy responders, and a biomarker panel was selected with high diagnostic ability for good-responding PDAC patients.

CANCER MEDICINE (2023)

Article Oncology

A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer

Jessica L. Chitty, Michelle Yam, Lara Perryman, Amelia L. Parker, Joanna N. Skhinas, Yordanos F. I. Setargew, Ellie T. Y. Mok, Emmi Tran, Rhiannon D. Grant, Sharissa L. Latham, Brooke A. Pereira, Shona C. Ritchie, Kendelle J. Murphy, Michael Trpceski, Alison D. Findlay, Pauline Melenec, Elysse C. Filipe, Audrey Nadalini, Sipiththa Velayuthar, Gretel Major, Kaitlin Wyllie, Michael Papanicolaou, Shivanjali Ratnaseelan, Phoebe A. Phillips, George Sharbeen, Janet Youkhana, Alice Russo, Antonia Blackwell, Jordan F. Hastings, Morghan C. Lucas, Cecilia R. Chambers, Daniel A. Reed, Janett Stoehr, Claire Vennin, Ruth Pidsley, Anaiis Zaratzian, Andrew M. Da Silva, Michael Tayao, Brett Charlton, David Herrmann, Max Nobis, Susan J. Clark, Andrew V. Biankin, Amber L. Johns, David R. Croucher, Adnan Nagrial, Anthony J. Gill, Sean M. Grimmond, Amber L. Johns, Anthony J. Gill, Lorraine A. Chantrill, Paul Timpson, Angela Chou, Marina Pajic, Tanya Dwarte, David Herrmann, Claire Vennin, Thomas R. Cox, Brooke A. Pereira, Shona C. Ritchie, Daniel A. Reed, Cecilia R. Chambers, Xanthe L. Metcalf, Max Nobis, Gloria Jeong, Lara Kenyon, Nicola Waddell, John V. Pearson, Ann-Marie Patch, Katia Nones, Felicity Newell, Pamela Mukhopadhyay, Venkateswar Addala, Stephen Kazakoff, Oliver Holmes, Conrad Leonard, Scott Wood, Sean M. Grimmond, Oliver Hofmann, Jaswinder S. Samra, Nick Pavlakis, Jennifer Arena, Hilda A. High, Ray Asghari, Neil D. Merrett, Amitabha Das, Peter H. Cosman, Kasim Ismail, Alina Stoita, David Williams, Allan Spigellman, Duncan Mcleo, Judy Kirk, James G. Kench, Peter Grimison, Charbel Sandroussi, Annabel Goodwin, R. Scott Mead, Katherine Tucker, Lesley Andrews, Michael Texler, Cindy Forrest, Mo Ballal, David Fletcher, Maria Beilin, Kynan Feeney, Krishna Epari, Sanjay Mukhedkar, Nikolajs Zeps, Nan Q. Nguyen, Andrew R. Ruszkiewicz, Chris Worthley, John Chen, Mark E. Brooke-Smith, Virginia Papangelis, Andrew D. Clouston, Andrew P. Barbour, Thomas J. O'Rourke, Jonathan W. Fawcett, Kellee Slater, Michael Hatzifotis, Peter Hodgkinson, Mehrdad Nikfarjam, James R. Eshleman, Ralph H. Hruban, Christopher L. Wolfgang, Aldo Scarpa, Rita T. Lawlor, Vincenzo Corbo, Claudio Bassi, Andrew V. Biankin, Nigel B. Jamieson, David K. Chang, Stephan B. Dreyer, Paul Timpson, Thomas R. Cox, Marina Pajic, Anthony J. Gill, Jaswinder S. Samra, Brooke A. Pereira, David Herrmann, Amber L. Johns, Gloria Jeong, Shona C. Ritchie, Daniel A. Reed, Cecilia R. Chambers, Janett Stoehr, Morghan C. Lucas, Joanna N. Skhinas, Lea Abdulkhalek, Max Nobis, Tatjana Schmitz, Victoria Lee, Xanthe L. Metcalf, Sean M. Grimmond, Kym Pham Stewart, Mehreen Arshi, Angela M. Steinmann, Lara Kenyon, Marina Pajic, Paul Timpson, Wolfgang Jarolimek, Thomas R. Cox

Summary: The pan-lysyl oxidase inhibitor PXS-5505 reduces chemotherapy-induced desmoplasia and stiffness, improving chemotherapy response and survival in pancreatic cancer models.

NATURE CANCER (2023)

暂无数据